PASG

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Passage Bio Inc

NASDAQ | PASG

8.93

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 17, 2025)

$28.13M

Market Cap

0.0286

P/E Ratio

309.14

EPS

$26.60

52 Week High

$5.12

52 Week Low

HEALTHCARE

Sector

PASG Chart

Recent Chart
Price Action

PASG Technicals

Tags:

PASG Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$3.1M
Total Revenue $0
Cost Of Revenue $3.1M
Costof Goods And Services Sold $3.1M
Operating Income -$70M
Selling General And Administrative $25M
Research And Development $40M
Operating Expenses $70M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.1M
Income Before Tax -$65M
Income Tax Expense -$1
Interest And Debt Expense -
Net Income From Continuing Operations -$65M
Comprehensive Income Net Of Tax -
Ebit -$65M
Ebitda -$62M
Net Income -$65M

Revenue & Profitability

Earnings Performance

PASG Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $102M
Total Current Assets $79M
Cash And Cash Equivalents At Carrying Value $38M
Cash And Short Term Investments $38M
Inventory -
Current Net Receivables -
Total Non Current Assets $24M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $39M
Other Current Assets $2.1M
Other Non Current Assets -
Total Liabilities $41M
Total Current Liabilities $19M
Current Accounts Payable $742K
Deferred Revenue -
Current Debt -
Short Term Debt $3.7M
Total Non Current Liabilities $22M
Capital Lease Obligations $25M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $25M
Other Current Liabilities $15M
Other Non Current Liabilities -
Total Shareholder Equity $61M
Treasury Stock -
Retained Earnings -$659M
Common Stock $6K
Common Stock Shares Outstanding $3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$48M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $3.1M
Capital Expenditures $34K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $55M
Cashflow From Financing $8.9M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $97K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$65M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$3.1M
Total Revenue $0
Cost Of Revenue $3.1M
Costof Goods And Services Sold $3.1M
Operating Income -$70M
Selling General And Administrative $25M
Research And Development $40M
Operating Expenses $70M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.1M
Income Before Tax -$65M
Income Tax Expense -$1
Interest And Debt Expense -
Net Income From Continuing Operations -$65M
Comprehensive Income Net Of Tax -
Ebit -$65M
Ebitda -$62M
Net Income -$65M

PASG News

PASG Profile

Passage Bio Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Passage Bio, Inc. is an innovative biotechnology company focused on developing gene therapies for rare monogenic disorders affecting the central nervous system. Headquartered in Philadelphia, Pennsylvania, the firm leverages its proprietary adeno-associated virus (AAV) delivery platform to create transformative treatments aimed at addressing significant unmet medical needs in neurology. With a robust pipeline of therapeutic candidates and strategic collaborations, Passage Bio is strategically positioned to make substantial advancements in the field of genetic medicine and enhance patient outcomes for those suffering from severe neurological diseases.

WTO
+26.35%
$0.03
LPTX
+368.57%
$2.05
VINE
+1.80%
$0.40
APLT
+27.39%
$0.27
AMIX
+57.96%
$1.14
KXIN
-9.26%
$0.27
VHAI
+33.33%
$0.00
NVDA
-2.77%
$184.89
CHR
-6.36%
$0.04
ONDS
-13.71%
$6.19
ASST
-8.54%
$0.98
GLMD
+9.61%
$1.14
TSLA
+0.45%
$406.19
AXDX
-61.36%
$0.03
GNS
-10.82%
$0.76
DVLT
+1.91%
$1.86
SOFI
-4.20%
$26.65
PLUG
-7.83%
$2.06
QUBT
+7.88%
$11.43
CIFR
-3.81%
$14.36
BYND
-5.09%
$1.02
DFLI
-8.26%
$0.74
PFE
+0.65%
$25.22
DNN
-4.84%
$2.35
ADAP
-15.14%
$0.05
ETHD
+11.65%
$5.83
RIVN
-3.70%
$14.55
INTC
-2.81%
$34.51
MKDW
-18.20%
$0.16
BMNR
-10.85%
$30.66
AMZN
-1.62%
$230.86
NIO
-1.21%
$6.08
BURU
-13.22%
$0.21
F
-2.31%
$12.88
ACHR
-7.61%
$7.28
MARA
-6.71%
$11.18
RMBL
+60.50%
$3.21
GOOGL
+2.76%
$284.04
LNW
-3.71%
$86.22
SNAP
-5.89%
$8.06
BITF
-1.22%
$2.54
ADD
-25.47%
$0.05
PLTR
-3.12%
$168.56
MSPR
+10.72%
$0.49
GPUS
-18.49%
$0.22
RGTI
-3.56%
$24.57
SRM
+53.27%
$10.30
RIG
+2.73%
$4.11
TLRY
-3.74%
$1.03
GRAB
-1.81%
$5.31
ASBP
-13.35%
$0.09
AAL
-3.21%
$12.35
AMD
-3.26%
$238.76
WULF
-1.94%
$10.77
XPEV
-10.83%
$22.29
WLGS
-5.57%
$0.04
PLTD
+3.50%
$7.07
HPE
-8.45%
$20.90
MTSR
-0.35%
$70.50
NOK
-0.31%
$6.70
IREN
-0.28%
$46.23
IONZ
+0.28%
$5.21
GOOG
+2.97%
$285.21
CAN
-5.80%
$0.84
QBTS
-5.16%
$22.39
AAPL
-1.89%
$267.26
HOOD
-7.23%
$113.63
TWOH
0.00%
$0.00
BTE
-4.69%
$3.01
AFMD
-34.94%
$0.18
BTBT
-5.08%
$2.28
BTG
-3.86%
$3.94
T
-0.29%
$25.51
AMC
-6.40%
$2.13
SMCI
-7.00%
$33.86
BBD
-1.36%
$3.62
MU
-2.11%
$241.60
IVVD
+20.14%
$2.82
CRWV
-4.87%
$73.58
BULL
-4.21%
$8.63
HIMS
-7.59%
$34.17
NBIS
+1.92%
$85.15
SOUN
-6.12%
$11.42
APLD
-2.51%
$23.05
CRCA
-15.77%
$4.05
KVUE
+2.13%
$17.01
OWL
-8.15%
$13.42
CLSK
-4.09%
$10.51
GRYP
-10.38%
$1.38
ABEV
-0.47%
$2.53
MODV
-25.22%
$0.43
JOBY
-4.50%
$13.76
EOSE
-6.34%
$12.92
RXRX
-2.29%
$4.04
CGC
-3.15%
$1.03
KMI
+1.97%
$27.42
IONQ
-0.48%
$46.95
PLTZ
+6.25%
$7.31
WBD
-2.14%
$22.53
CRCL
-7.87%
$75.44
WTO
+26.35%
$0.03
LPTX
+368.57%
$2.05
VINE
+1.80%
$0.40
APLT
+27.39%
$0.27
AMIX
+57.96%
$1.14
KXIN
-9.26%
$0.27
VHAI
+33.33%
$0.00
NVDA
-2.77%
$184.89
CHR
-6.36%
$0.04
ONDS
-13.71%
$6.19
ASST
-8.54%
$0.98
GLMD
+9.61%
$1.14
TSLA
+0.45%
$406.19
AXDX
-61.36%
$0.03
GNS
-10.82%
$0.76
DVLT
+1.91%
$1.86
SOFI
-4.20%
$26.65
PLUG
-7.83%
$2.06
QUBT
+7.88%
$11.43
CIFR
-3.81%
$14.36
BYND
-5.09%
$1.02
DFLI
-8.26%
$0.74
PFE
+0.65%
$25.22
DNN
-4.84%
$2.35
ADAP
-15.14%
$0.05
ETHD
+11.65%
$5.83
RIVN
-3.70%
$14.55
INTC
-2.81%
$34.51
MKDW
-18.20%
$0.16
BMNR
-10.85%
$30.66
AMZN
-1.62%
$230.86
NIO
-1.21%
$6.08
BURU
-13.22%
$0.21
F
-2.31%
$12.88
ACHR
-7.61%
$7.28
MARA
-6.71%
$11.18
RMBL
+60.50%
$3.21
GOOGL
+2.76%
$284.04
LNW
-3.71%
$86.22
SNAP
-5.89%
$8.06
BITF
-1.22%
$2.54
ADD
-25.47%
$0.05
PLTR
-3.12%
$168.56
MSPR
+10.72%
$0.49
GPUS
-18.49%
$0.22
RGTI
-3.56%
$24.57
SRM
+53.27%
$10.30
RIG
+2.73%
$4.11
TLRY
-3.74%
$1.03
GRAB
-1.81%
$5.31
ASBP
-13.35%
$0.09
AAL
-3.21%
$12.35
AMD
-3.26%
$238.76
WULF
-1.94%
$10.77
XPEV
-10.83%
$22.29
WLGS
-5.57%
$0.04
PLTD
+3.50%
$7.07
HPE
-8.45%
$20.90
MTSR
-0.35%
$70.50
NOK
-0.31%
$6.70
IREN
-0.28%
$46.23
IONZ
+0.28%
$5.21
GOOG
+2.97%
$285.21
CAN
-5.80%
$0.84
QBTS
-5.16%
$22.39
AAPL
-1.89%
$267.26
HOOD
-7.23%
$113.63
TWOH
0.00%
$0.00
BTE
-4.69%
$3.01
AFMD
-34.94%
$0.18
BTBT
-5.08%
$2.28
BTG
-3.86%
$3.94
T
-0.29%
$25.51
AMC
-6.40%
$2.13
SMCI
-7.00%
$33.86
BBD
-1.36%
$3.62
MU
-2.11%
$241.60
IVVD
+20.14%
$2.82
CRWV
-4.87%
$73.58
BULL
-4.21%
$8.63
HIMS
-7.59%
$34.17
NBIS
+1.92%
$85.15
SOUN
-6.12%
$11.42
APLD
-2.51%
$23.05
CRCA
-15.77%
$4.05
KVUE
+2.13%
$17.01
OWL
-8.15%
$13.42
CLSK
-4.09%
$10.51
GRYP
-10.38%
$1.38
ABEV
-0.47%
$2.53
MODV
-25.22%
$0.43
JOBY
-4.50%
$13.76
EOSE
-6.34%
$12.92
RXRX
-2.29%
$4.04
CGC
-3.15%
$1.03
KMI
+1.97%
$27.42
IONQ
-0.48%
$46.95
PLTZ
+6.25%
$7.31
WBD
-2.14%
$22.53
CRCL
-7.87%
$75.44
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.